Health impacts of breast implants and other cosmetic procedures

Status / emerging findings

• Non-surgical cosmetic procedures exist in a regulatory 'wild west': procedures occur in Airbnbs, garden sheds, and public toilets with no licensing, training standards, or mandatory reporting—the committee calls for immediate legislative action and an immediate ban on liquid Brazilian butt lifts (BBLs), which have caused fatalities.
• Breast implant surveillance is broken: the UK registry hasn't published annual reports since June 2023, 40–50% of implant recipients experience negative side effects, yet the condition lacks disease classification and GPs routinely dismiss symptoms; France compensated 30,000 women for PIP implants, the UK compensated none.
• The MHRA and NHS maintain PIP implants carry no proven toxicological risk despite higher rupture rates and acknowledge under-reporting of 'breast implant illness' (only ~1,000 reports from 300,000+ operations); expert witnesses called this position 'ludicrous.'
• Psychological vulnerability is ignored: 15% of cosmetic surgery patients have body dysmorphic disorder (vs. 2% population baseline) with 5x higher suicide rates, yet no mandatory screening exists; social media algorithms actively target vulnerable users with cosmetic procedure adverts.
• Cross-border arbitrage and uneven regulation: Wales and Northern Ireland lack requirements that exist in England and Scotland; practitioners exploit jurisdictional gaps; the UK is an outlier—only it, Ireland, US, and Canada allow non-medically qualified people to perform cosmetic procedures.

Why it matters

Tens of thousands of UK women have received unsafe or unregulated cosmetic procedures with no legal recourse, inadequate medical tracking, or psychological safeguards; the NHS bears the cost of complications while regulators have resisted action despite evidence of preventable harm.

Tone arc

Started procedural and cooperative in May 2025 (expert witnesses outlining evidence gaps), became sharply adversarial in July when MHRA and NHS defended their risk assessment approach and acknowledged under-reporting, shifted to urgent and critical by October with calls for immediate legislative bans and regulatory overhaul.

Key witnesses

Victoria Brownlie MBE (British Beauty Council), Lesley Blair MBE (British Association of Beauty Therapy and Cosmetology), Professor Carl Heneghan (Oxford, breast implant registry expert), Professor Prabath Nanayakkara (NHS, breast implant illness), Professor Michael Coleman (epidemiology, PIP implants), Dr Alison Cave (MHRA), Dr Beth Daniels (body image, mental health), Dr Christopher Roland Payne (cosmetic surgeon)